Longitude Capital Partners III, LLC Insider Trading $INZY Inozyme Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Longitude Capital Partners III, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Longitude Capital Partners III, LLC. Longitude Capital Partners III, LLC is 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in Sierra Oncology, Inc. ($SRRA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in 89bio, Inc. ($ETNB) and 10% Owner in Talaris Therapeutics, Inc. ($TALS).
Longitude Capital Partners III, LLC in Inozyme Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 2,007,225 shares
Latest Transaction: Jul 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Longitude Capital Partners III, LLC in Inozyme Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, AXNX, INZY, MTEM, SRRA, TALS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,398,600 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 625,000 | 10,000,000 | 2,819,379 | 2.2 M to 2.8 M (+28.48 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 187,154 | 0 | 2,194,379 | 2 M to 2.2 M (+9.32 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 2,007,225 | 0 | 2,007,225 | 0 to 2 M |
Page: 1